Effect of Early Treatment with Ivermectin among Patients with Covid-19

BACKGROUND: The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Gilmar, Silva, Eduardo A.S.M., Silva, Daniela C.M., Thabane, Lehana, Milagres, Aline C., Ferreira, Thiago S., dos Santos, Castilho V.Q., Campos, Vitoria H.S., Nogueira, Ana M.R., de Almeida, Ana P.F.G., Callegari, Eduardo D., Neto, Adhemar D.F., Savassi, Leonardo C.M., Simplicio, Maria I.C., Ribeiro, Luciene B., Oliveira, Rosemary, Harari, Ofir, Forrest, Jamie I., Ruton, Hinda, Sprague, Sheila, McKay, Paula, Guo, Christina M., Rowland-Yeo, Karen, Guyatt, Gordon H., Boulware, David R., Rayner, Craig R., Mills, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006771/
https://www.ncbi.nlm.nih.gov/pubmed/35353979
http://dx.doi.org/10.1056/NEJMoa2115869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006771/
https://www.ncbi.nlm.nih.gov/pubmed/35353979
http://dx.doi.org/10.1056/NEJMoa2115869

Ejemplares similares